NECTIN4-directed CAR-T cells demonstrated potent cytotoxicity across urothelial carcinoma cells expressing varying levels of endogenous NECTIN4, including those resistant to enfortumab vedotin. The gene discussed is NECTIN4; the disease is urothelial carcinoma.